These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23443310)

  • 21. A part-randomized study of intravenous oseltamivir in adolescents and adults.
    Várkonyi I; Chappey C; Giraudon M; Burleigh L
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1181-8. PubMed ID: 25678009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.
    Davies BE
    J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii5-ii10. PubMed ID: 20215135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.
    Pai MP; Lodise TP
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5640-5. PubMed ID: 21930881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
    Dulek DE; Williams JV; Creech CB; Schulert AK; Frangoul HA; Domm J; Denison MR; Chappell JD
    Clin Infect Dis; 2010 Jun; 50(11):1493-6. PubMed ID: 20415572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
    Kumar A
    J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.
    Beigi RH; Han K; Venkataramanan R; Hankins GD; Clark S; Hebert MF; Easterling T; Zajicek A; Ren Z; Mattison DR; Caritis SN;
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S84-8. PubMed ID: 21492826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unit.
    Standing JF; Nika A; Tsagris V; Kapetanakis I; Maltezou HC; Kafetzis DA; Tsolia MN
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3833-40. PubMed ID: 22564835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
    Wildschut ED; de Hoog M; Ahsman MJ; Tibboel D; Osterhaus AD; Fraaij PL
    PLoS One; 2010 Jun; 5(6):e10938. PubMed ID: 20532176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir pharmacokinetics in pregnancy: a commentary.
    Mirochnick M; Clarke D
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S94-5. PubMed ID: 21640232
    [No Abstract]   [Full Text] [Related]  

  • 32. Pandemic (H1N1) 2009 virus infection: prolonged viral shedding and the role of corticosteroids.
    Rapose A
    J Infect; 2012 Sep; 65(3):281-2; author reply 282. PubMed ID: 22561090
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of unwanted effects of oseltamivir carboxylate in juvenile rats after subcutaneous administration.
    Freichel C; Breidenbach A; Gand L; Toot J; Weiser T; Körner A; Singer T; Prinssen E; Hoffmann G
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):551-3. PubMed ID: 22145997
    [No Abstract]   [Full Text] [Related]  

  • 34. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
    Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
    Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
    [No Abstract]   [Full Text] [Related]  

  • 36. Choice of oseltamivir in 2009 flu pandemic was "worrying," says MP.
    Kmietowicz Z
    BMJ; 2013 May; 346():f3371. PubMed ID: 23704131
    [No Abstract]   [Full Text] [Related]  

  • 37. Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.
    Lackenby A; Elliot AJ; Powers C; Andrews N; Ellis J; Bermingham A; Thompson C; Galiano M; Large S; Durnall H; Fleming D; Smith G; Zambon M
    J Antimicrob Chemother; 2013 Oct; 68(10):2324-31. PubMed ID: 23759670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.
    Ilyushina NA; Donnelly RP
    Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
    Karsch K; Chen X; Miera O; Peters B; Obermeier P; Francis RC; Amann V; Duwe S; Fraaij P; Heider A; de Zwart M; Berger F; Osterhaus A; Schweiger B; Rath B
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):155-164. PubMed ID: 26994602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza.
    Favié LM; Murk JL; Meijer A; Nijstad AL; van Maarseveen EM; Sikma MA
    Antivir Ther; 2018; 23(5):457-461. PubMed ID: 29185991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.